Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 13Colonic Neoplasms 2Stomach Neoplasms 1Metastatic Gastric Adenocarcinoma 1Gastric and Gastroesophageal Junction Adenocarcinoma 1Gastric Cancer Adenocarcinoma Metastatic 1Gastric Adenocarcinoma 1Advanced Gastric Cancer 1

Interventions

apatinib 8Paclitaxel 7Capecitabine 7Oxaliplatin 6Cisplatin 5camrelizumab 4S 1 (combination) 3Fluorouracil 3130-nm albumin-bound paclitaxel 3Leucovorin 2Drug Therapy 2Docetaxel 2trifluridine tipiracil drug combination 1titanium silicide 1tipiracil 1raltitrexed 1pazopanib 1olaparib 1lobaplatin 1ezogabine 1endostar protein 1durvalumab 1dacomitinib 1capivasertib 1Trifluridine 1Sunitinib 1SHR-1701 1Ramucirumab 1Metabolic Networks and Pathways 1Irinotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Gastric Cancer × tipiracil × Clear all
NCT07371871 2026-01-28

A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer

Anhui Provincial Cancer Hospital

Phase NA Not yet recruiting
30 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡